Related by context. All words. (Click for frequent words.) 63 comorbid conditions 62 hereditary predisposition 61 androgen deficiency 61 breast endometrial 61 familial predisposition 61 comorbid depression 61 impaired glucose metabolism 60 comorbid illnesses 60 comorbidities 60 comorbid disorders 60 macrovascular disease 60 extrapyramidal symptoms 60 hypertension hypercholesterolemia 60 nonischemic 60 Genetic predisposition 60 Cognitive impairment 59 impaired cognition 59 baseline serum creatinine 59 underlying pathophysiology 59 metabolic syndromes 59 Chronic pancreatitis 59 dyslipidaemia 59 autonomic dysfunction 58 lipid concentrations 58 neurological abnormalities 58 SE alleles 58 intracranial atherosclerosis 58 Excessive daytime sleepiness 58 Erythropoietic therapies may 58 elevated triglyceride levels 58 affective psychosis 57 chronic metabolic acidosis 57 inhaled glucocorticoids 57 psychiatric comorbidities 57 hypertension diabetes mellitus 57 familial clustering 57 dyslipidemia hypertension 57 neutropenia thrombocytopenia 57 SIADH 57 mild renal insufficiency 57 macrovascular events 57 lipid lowering agents 57 carotid plaques 57 diabetes dyslipidemia 57 gastrointestinal GI bleeding 57 unmeasured factors 57 malperfusion 57 β blockers 57 microangiopathy 57 hormonal abnormalities 57 potentially modifiable 57 neurologic abnormalities 57 PLX STROKE targeting 57 somatic complaints 57 CLBP 56 progressive dyspnea 56 nonhereditary 56 dermatologic reactions 56 left ventricular diastolic 56 prostate cancer CaP 56 underdiagnosis 56 subsyndromal 56 Pernicious anemia 56 elevated fasting glucose 56 impaired insulin secretion 56 microvascular disease 56 LV dysfunction 56 metabolic abnormalities 56 nonfasting triglyceride levels 56 rheumatoid arthritis lupus 56 receiving XGEVA 56 psychiatric comorbidity 56 nonalcoholic steatohepatitis NASH 56 hypercoagulable 56 predisposing factor 56 hyperglycaemia 56 affective psychoses 56 ventricular tachyarrhythmia 56 neurologic complications 56 Sleep disordered breathing 56 untreated hypothyroidism 56 vascular dysfunction 56 microbleeds 56 co morbidities 56 macrovascular complications 56 OSAHS 56 cardio metabolic diseases 56 proinflammatory cytokine 56 noncardiac 56 variant angina 56 echocardiographic parameters 56 untreated celiac disease 56 dyslipidemias 56 blindness paralysis 56 hyperinsulinemia 55 circulating estrogens 55 carotid artery blockage 55 arteriosclerotic 55 subclinical hypothyroidism 55 abnormal lipid levels 55 psychomotor retardation 55 somatic symptoms 55 mucosal inflammation 55 lupus scleroderma 55 elevated serum creatinine 55 coagulopathy 55 comorbidity 55 Vitamin B# deficiency 55 syndrome OSAS 55 nondiabetic patients 55 Aortic stenosis 55 limiting generalizability 55 comorbid anxiety 55 perceptual biases 55 cardiovascular disease hypertension 55 etiologies 55 diastolic BP 55 Atypical antipsychotics 55 primary aldosteronism 55 abnormal glucose tolerance 55 abnormal lipids 55 pharmacologic therapy 55 symptom flare ups 55 Endothelial dysfunction 55 hypertensives 55 PR interval prolongation 55 hypokalemia hypomagnesemia 55 obesity sedentary lifestyle 55 poorer prognosis 55 painful menstrual periods 55 Genetic variants 55 renal insufficiency 55 euthymic 55 cryptogenic 55 neurologic symptoms 55 Angiotensin converting enzyme 55 insulin resistance precursor 55 CVD mortality 55 obese postmenopausal 55 non ulcer dyspepsia 55 tumor subtype 55 lipid abnormalities 55 subclinical hyperthyroidism 55 pharmacologic treatments 55 tamoxifen Nolvadex ® 55 pancreatic endocrine 55 nasopharyngitis headache 55 anticholinergic effects 54 hypertension cardiovascular disease 54 leukopenia 54 postmenopausal hormones 54 psychomotor agitation 54 glucose abnormalities 54 maintaining cardiorespiratory fitness 54 beta carotene supplementation 54 CYP #A# 54 Hormonal imbalances 54 Testosterone deficiency 54 obstructive coronary artery 54 unipolar depression 54 thromboembolic complications 54 elevated IOP 54 nodal metastases 54 Oxidative damage 54 thiazide 54 vitamin D inadequacy 54 heritable disorders 54 neovascular glaucoma 54 subclinical disease 54 gastric cardia 54 atherosclerosis plaque buildup 54 MYH9 54 multiple sclerosis psoriasis 54 #q#.# deletion syndrome 54 C1 INH deficiency 54 predisposing factors 54 metabolic dysfunction 54 hormone receptor negative 54 coronary revascularizations 54 Hashimoto thyroiditis 54 multivariate adjustment 54 emphysema bronchitis 54 adenomatous polyps 54 renal fibrosis 54 inflammatory bowel syndrome 54 insomnia somnolence 54 neuropsychological impairments 54 thyrotoxicosis 54 carbohydrate intolerance 54 oral hypoglycemic agents 54 unmeasured confounders 54 aMCI precursor 54 angina chest 54 systolic dysfunction 54 poststroke 54 gestational diabetes mellitus 54 comorbid 54 neurocognitive deficits 54 metabolic disturbances 54 perioperative complications 54 lethargy irritability 54 gastric atrophy 54 hypochondriasis 54 testicular tumors 54 familial aggregation 54 convulsive disorders 54 prostate carcinogenesis 54 parenchymal 54 postoperative AF 54 sweats vaginal dryness 54 Rachel Ballard Barbash 54 elevated hsCRP 54 Korsakoff syndrome 54 obesity insulin resistance 54 neurocognitive impairment 54 motor tics 54 headache nasopharyngitis 54 menstrual irregularities 54 Autoimmune hepatitis 54 hypoxemia 54 neuropsychological impairment 54 Sugar sweetened beverages 54 modifiable lifestyle 54 SLC#A# [002] 54 residual confounding 53 drowsiness nausea 53 chronic periodontitis 53 left ventricular systolic 53 CHD CVD 53 normotensive 53 diabetes mellitus hypertension 53 elevated triglycerides 53 coinfected patients 53 infarcts 53 euthymic patients 53 APOE genotype 53 proliferative diabetic retinopathy 53 HIV HCV coinfected 53 COPD asthma 53 angiotensin II receptor blockers 53 COPD emphysema 53 fibroids endometriosis 53 obstructive coronary 53 abnormal vaginal bleeding 53 hypertension coronary 53 intima media thickness 53 nonobstructive 53 type2 diabetes 53 pharmacological approaches 53 Calcium intake 53 renal dysfunction 53 alexithymia 53 EEG abnormalities 53 dopamine antagonists 53 intracerebral haemorrhage 53 subclinical atherosclerosis 53 thrombo embolic 53 nausea vomiting constipation 53 multivessel disease 53 angina myocardial infarction 53 glial tumors 53 Chronic constipation 53 AGGRASTAT R tirofiban hydrochloride 53 nondemented 53 hypoperfusion 53 androgen excess 53 lipid lowering medications 53 hypercalcaemia 53 anatomical abnormalities 53 MMSE scores 53 endogenous estrogen 53 BRCA1 mutation carriers 53 affective disorders 53 choroidal neovascularization 53 carotid stenosis 53 neurodevelopmental impairment 53 Diabetic macular edema 53 contralateral breast cancer 53 airway reactivity 53 Chronic ITP 53 cardioprotective effect 53 orchitis 53 arthritis lupus 53 decompensated cirrhosis 53 Diabetic neuropathy 53 primidone 53 Undesirable alterations 53 serum creatinine levels 53 deCODE Glaucoma TM 53 hypersomnia 53 systemic autoimmune 53 hyperhydrosis 53 biochemical abnormalities 53 acetabular dysplasia 53 symptomatic intracerebral hemorrhage 53 typical antipsychotics 53 atrophic gastritis 53 nonpharmacological treatments 53 cirrhotic liver 53 serum leptin 53 anemia neutropenia 53 Adverse effects 53 vitreous floaters 53 pyrexia mucositis sepsis febrile 53 childbearing age mirrors 53 ataxias 53 acid regurgitation 53 arterial calcification 53 gallstone disease 53 Abdominal obesity 53 malabsorptive 53 hepatic renal 53 cardiac malformations 53 mu opioid agonists 53 Neuroticism 53 habitual snoring 53 cognitively intact 53 genetic loci 53 vomiting drowsiness 53 Comorbid 53 aortic insufficiency 53 muscles abdominal distension 53 cerebral microbleeds 53 Bacterial vaginosis 53 metabolic dysregulation 53 Hoarseness 53 metabolic derangements 53 hyperalgesia 53 antioxidant supplementation 53 phytoestrogen intake 53 subcortical 53 Hypocalcemia 53 skeletal metastases 53 transfusion syndrome 53 ischemia acute myocardial 53 blindness amputation 53 GABRA2 53 Socioeconomic factors 53 asymptomatic PAD 53 P = .# 53 cardiovascular morbidity 53 insomnia dizziness 53 Peripheral edema 53 catheter angiography 53 post herpetic 53 hypoactive 53 KIF6 carriers 53 progesterone receptor negative 53 Body dysmorphic disorder 53 gallbladder disease 53 aetiology 53 overt nephropathy 53 Uncontrolled hypertension 53 ATACAND 53 lipid levels 53 Subclinical 53 dysfunctional voiding 52 myocardial ischemia 52 NAFLD 52 thrombocytopenia neutropenia 52 nausea constipation 52 syndromal 52 Crohn disease CD 52 moderate renal impairment 52 kidney urologic 52 ecchymosis 52 nonalcoholic steatohepatitis 52 thyrotropin levels 52 Fanconi syndrome 52 vascular occlusive diseases 52 microvascular dysfunction 52 seminomas 52 extrapyramidal symptoms EPS 52 cytopenias 52 coronary stenosis 52 cardioprotection 52 insulin sensitizing agents 52 arterial inflammation 52 Myocardial infarction 52 menopause andropause 52 HNSCC 52 LDL cholesterol concentrations 52 unmeasured confounding 52 dysuria 52 comorbid substance 52 Exclusion criteria 52 abdominal adiposity 52 antihypertensive therapy 52 familial pancreatic cancer 52 antenatal depression 52 dysmotility 52 nausea diarrhea fatigue 52 atherogenic dyslipidemia 52 severe mitral regurgitation 52 haemorrhagic stroke 52 dysarthria 52 urinary bowel 52 coexisting illnesses 52 benign moles 52 Prognostic factors 52 inflammatory biomarkers 52 childhood disintegrative disorder 52 abdominal visceral fat 52 radiographic findings 52 severe periodontitis 52 edema thrombosis pulmonary thromboembolism 52 ADPKD 52 Elevated CRP 52 TNF blocker therapy 52 glucose intolerance 52 recurrent acute pancreatitis 52 carotid plaque 52 hormone receptor status 52 immunological reaction 52 fatigue abdominal pain 52 antiangiogenic therapy 52 hematopoietic cancers 52 cyclooxygenase 2 52 bothersome symptom 52 nephrolithiasis 52 baseline HbA1c 52 vascular cognitive impairment 52 neurocognitive dysfunction 52 psychosocial stressors 52 proteinuria 52 dysthymic 52 prognostic factors 52 dysthymic disorder 52 missense mutations 52 Colon polyps 52 multiple sclerosis inflammatory bowel 52 ABCB1 52 diabetic microvascular complications 52 digestive disturbances 52 contralateral breast 52 MYH9 gene 52 parkinsonism 52 outside nongenetic factors 52 lymphadenopathy 52 lung cancer NSCLC 52 decreased libido 52 Depressive symptoms 52 arterial thickening 52 sulphonylureas 52 rCBF 52 probiotic supplementation 52 Magnesium deficiency 52 atypical hyperplasia 52 abnormal glucose metabolism 52 fatigue skin rashes 52 pressure squeezing fullness 52 epilepsy Parkinson disease 52 TT genotype 52 hyperreflexia 52 obstructive sleep 52 axillary node 52 noncardiovascular 52 cervical lymph nodes 52 atopic asthma 52 nondepressed 52 folate metabolism 52 AGGRASTAT ® tirofiban hydrochloride 52 pancreas pancreatitis 52 ß blockers 52 breast tenderness bloating 52 asthma bronchitis emphysema 52 CP CPPS 52 obstructive CAD 52 diabetic kidney 52 Alzheimer pathology 52 ALB # 52 triglyceride lowering 52 headache abdominal pain 52 nonmelanoma 52 confidence interval #.#-#.# 52 Orthostatic hypotension 52 Subgroup analyzes 52 cardiomyopathies 52 squamous cell histology 52 impaired endothelial 52 postmenopausal hormone 52 thromboembolic disease 52 fibrate drugs 52 pancreatic adenocarcinoma 52 cardiac dysfunction 52 plasma lipids 52 emotional lability 52 embolic stroke 52 rheumatic disease 52 gene polymorphisms 52 locoregional recurrence 52 lichen planus 52 hamartomas 52 discomfort bloating 52 Luo Odinga 52 prothrombotic 52 muscular stiffness 52 psychosocial functioning 52 % CI #.#-#.# [006] 52 Fluid retention 52 transferrin saturation 52 Androgenetic alopecia 52 antiphospholipid antibodies 52 Inflammatory bowel diseases 52 anticholinergic agents 52 MetS 52 Baseline characteristics 52 TEAEs 52 histologic subtypes 52 breast cancer subtypes 52 left ventricular dysfunction 52 dysphonia 52 ventricular dilation 52 MGUS 52 Acid reflux disease 52 preserved ejection fraction 52 somatoform disorder 52 modifiable cardiovascular 52 thromboembolic 52 somatoform disorders 52 Opportunistic infections 52 behavioral abnormalities 52 prognostic indicators 52 Fecal incontinence 52 atherosclerotic coronary 52 electrolyte abnormalities 51 HBeAg negative 51 hyperinsulinism 51 osteosarcomas 51 headache nausea fatigue 51 neoplastic 51 CYP#C# genotype 51 cerebral infarction 51 tumor histology 51 mammographically 51 pathological hallmark 51 artery stenosis 51 white matter hyperintensities 51 soluble CD# ligand 51 cholestatic jaundice 51 etiological factors 51 nasal obstruction 51 autoimmune pancreatitis 51 Daytime sleepiness 51 abnormal lipid 51 sociodemographic characteristics 51 somnolence sleepiness 51 Nasal polyps 51 serum PTH 51 Meningiomas usually occur 51 Univariate analysis 51 Incretin mimetics 51 lymphopenia 51 thalassemia sickle cell 51 sociodemographic factors 51 hippocampal volumes 51 cortical dysplasia 51 advanced adenomas 51 interstitium 51 vascular Ehlers Danlos 51 depression suicidal ideation 51 constipation nausea 51 GBA mutations 51 thrombosis blood clots 51 serotonin neurotransmission 51 Chest x rays 51 amenorrhoea 51 thyroid deficiency 51 ischemic cardiomyopathy 51 plasma homocysteine 51 completely resected 51 severe renal insufficiency 51 carotid atherosclerosis 51 perimenopausal women 51 inappropriate antidiuretic hormone SIADH 51 chorioamnionitis 51 vWD 51 progesterone receptor PR 51 interstitial nephritis 51 amputation blindness 51 elevated LDL cholesterol 51 LUTS 51 preeclampsia gestational diabetes 51 onset diabetes mellitus 51 delta gamma agonist 51 newer antipsychotics 51 coronary calcification 51 Genetic variations 51 Angiograms carry slight 51 pathophysiologic mechanisms 51 included exfoliative dermatitis 51 post transplant lymphoproliferative 51 frontal lobe dysfunction 51 CI #.#-#.# [001] 51 hyperparathyroidism 51 depressive symptomatology 51 lenalidomide dexamethasone 51 confusional arousals 51 minimally symptomatic 51 statistically significant predictor 51 MTHFD1L gene 51 mitochondrial metabolism 51 headache drowsiness 51 epigastric pain 51 atherosclerotic cardiovascular 51 abnormal clotting 51 nonfasting triglycerides 51 overdiagnose 51 hypogonadotropic hypogonadism 51 hypovitaminosis D 51 myopathies 51 exertional dyspnea 51 NPH insulin 51 elevated LDH 51 PTEN mutations 51 prescribe statins 51 periprocedural MI 51 arthritis osteoporosis 51 fatal IHD 51 Computerized tomography 51 ventricular hypertrophy 51 cardiac fibrosis 51 psychopathologies 51 schizotypal 51 Venous thromboembolism 51 mammographic breast density 51 lymphomas leukemias 51 Diastolic dysfunction 51 chronicity 51 poststroke depression 51 laboratory abnormalities 51 severe obstructive sleep 51 Myotonic dystrophy 51 lipoprotein profiles 51 atherothrombosis 51 cardio metabolic 51 dyslipidemic 51 colic diarrhea 51 biologic pathways 51 bronchodilator therapy 51 nonsteroidal antiinflammatory drugs 51 psychopathological disorders 51 neurosensory 51 narcolepsy cataplexy 51 diabetes hypertension hyperlipidemia 51 Diabetic peripheral neuropathy 51 Heavy snorers 51 hypercholesterolaemia 51 systemic inflammation 51 dystonias 51 esophagus colon 51 carotid IMT 51 Dr. Issa Dahabreh 51 NUCYNTA ™ 51 immunosuppressive regimen 51 metabolic parameters 51 cardiometabolic disorders 51 lipid lowering therapy 51 natriuresis 51 NSAID induced GI 51 Menstrual migraines 51 albuminuria 51 comorbid psychiatric 51 heterozygous familial 51 constipation hemorrhoids 51 prematurity Stargardt disease 51 systolic function 51 behavioral disturbances 51 colorectal adenoma 51 diastolic blood pressures 51 unprovoked seizures 51 Elevated triglycerides 51 nonhematologic adverse reactions 51 Avandia Actos 51 PCNSL 51 nulliparous women 51 carotid bruit 51 BMI ≥ 51 squamous histology 51 mental retardation epilepsy 51 abdominal tenderness 51 polyp recurrence 51 malignant lesions 51 non cirrhotic portal 51 Multivariate analyzes 51 Sleep disturbances 51 cardiopulmonary diseases 51 lipid lowering therapies 51 QT interval prolongation 51 BRCA2 carriers 51 gangrene amputation 51 nonblacks 51 Untreated sleep apnea 51 ovarian carcinoma 51 atherothrombotic 51 Evidence Therapeutic study 51 metformin monotherapy 51 Radical prostatectomy 51 morbidities 51 somnolence dizziness 51 postural hypotension 51 corticosteroid therapy 51 dizziness nausea headaches 51 respiratory gastrointestinal 51 Bulimia nervosa 51 myeloproliferative diseases 51 nonadherent 51 sweating nausea 51 dysglycemia 51 sequela 51 Secondhand smoke exposure 51 electrolyte imbalances 51 opioid naive 51 CYT# potent vascular disrupting 51 2 diabetes T2D 51 neuroinflammatory 51 chronic prostatitis chronic 51 Acid reflux 51 plasminogen activators 51 transaminase elevations 51 clinicopathological 51 Personality traits 51 Maternal obesity 51 diarrhea headache nausea 51 juvenile idiopathic arthritis JIA 51 degenerative neurological diseases 51 tonic clonic seizures 51 monoamine neurotransmitters 51 FGFs 51 coughing wheezing shortness 51 lymphocytic 51 brain lesions 51 HbA1C levels 51 thiopurine 51 beta blocker therapy 51 shorter telomere length 51 systemic corticosteroid 51 Lactose intolerance 51 endothelial activation 51 DNA methylation patterns 51 coronary blockages 51 androgen hormone 51 elevated CRP 51 Adjuvant chemotherapy 51 lipid elevations 51 cirrhotic 51 serous ovarian cancer 51 blindness amputations 51 progressive neurologic 51 Suicidal ideation 51 visceral adiposity 51 Chronic bronchitis 50 esophageal reflux 50 hyperintensities 50 metabolic abnormality 50 mood swings irritability 50 Ischemic heart 50 antiphospholipid syndrome 50 total cholesterol triglycerides 50 catastrophizing 50 genetic determinants 50 sleepiness nausea 50 parous women 50 cognitive dysfunctions 50 clinically meaningful reductions 50 parkinsonian 50 frontostriatal 50 severe renal impairment 50 Shortened telomeres 50 HMG CoA reductase inhibitors 50 hemodilution 50 depression irritability 50 inherited predisposition 50 insulin resistance syndrome 50 detrusor overactivity 50 socioeconomic gradient 50 multisystem disease 50 anorexia nervosa bulimia 50 rheumatic disorders 50 dysregulated 50 diarrhea constipation 50 lumbar disk herniation 50 prognostically 50 lion Frese 50 interindividual variability 50 dopamine neuron 50 stable angina 50 angiographically 50 strong CYP#A# inducers 50 rheumatological 50 liver histology 50 ischemic diseases 50 cathepsins 50 antiarrhythmic drug 50 progressive degenerative neurological 50 irritability fatigue 50 Nutritional deficiencies 50 NUCYNTA R 50 GRK5 50 mucocutaneous 50 Subclinical hypothyroidism 50 neurodegenerative disorder characterized 50 hormonally responsive 50 Von Willebrand disease 50 Aggrastat ® tirofiban hydrochloride 50 irregular menses 50 abdominal distension 50 receptor subtypes 50 plasma homocysteine levels 50 diastolic pressures 50 asplenia 50 nephropathy 50 bowel incontinence 50 mitochondrial mutations 50 myopathy rhabdomyolysis 50 amnestic MCI 50 Chemotherapy induced 50 gastro oesophageal reflux 50 pulmonary capillary wedge 50 NorStates Bank serves 50 COX inhibitors 50 leptin deficiency 50 ejection fractions 50 PNH patients 50 lymph node involvement 50 drank colas 50 headaches drowsiness 50 Sjögren syndrome 50 antiarrhythmic medications 50 fasting triglyceride levels 50 gastrointestinal disturbances 50 postoperative pulmonary 50 nondiabetics 50 pathophysiological mechanisms 50 thyrotropin 50 Peripheral arterial disease 50 vasodilators 50 proximal colon 50 hepatic fibrosis 50 paroxysmal AF 50 neurohormonal activation 50 inherited mutations 50 gastro esophageal reflux disease 50 treatment emergent hyperglycemia 50 etiologic factors 50 treating psychiatric disorders 50 cardiovascular mortality 50 nonadherence 50 frequent bowel movements 50 nausea vomiting headache 50 BMPR2 50 airflow limitation 50 CYP#D# inhibitors 50 prostate pancreatic 50 slow metabolizers 50 del 5q MDS 50 Idiopathic pulmonary fibrosis IPF 50 Hypertensive 50 lipodystrophy syndrome 50 nondiabetic 50 psychosocial variables 50 inflammatory rheumatic 50 ischemic vascular 50 jihadi awakening 50 waist circumference WC 50 cola drinkers 50 p#INK#a 50 gestational diabetes mellitus GDM 50 constipation bloating 50 impaired renal 50 postoperative morbidity 50 response syndrome SIRS 50 confounding variables 50 metaplasia 50 Rectal bleeding 50 5 HTTLPR 50 pancreatic prostate 50 clinicopathologic 50 Thalomid ® 50 serum triglycerides 50 NADPH oxidase 50 APOE ε4 50 dysphoric 50 susceptibility loci 50 serum phosphate levels 50 KCNH2 50 obstructive lung 50 estradiol gel indicated 50 MMSE score 50 irritability insomnia 50 disease NAFLD 50 HIV lipodystrophy 50 vomiting constipation 50 Tasigna prolongs 50 cystic fibrosis chronic pancreatitis 50 sotalol 50 Systemic lupus erythematosus SLE 50 MACCE 50 serum urate levels 50 hepatic steatosis 50 rhinitis sinusitis 50 Calcium vitamin D 50 hepatomegaly 50 nonpharmacologic 50 nausea respiratory distress 50 Kaplan Meier curve 50 lipoprotein metabolism 50 glomerulonephritis 50 paraneoplastic 50 Cardiopulmonary bypass 50 motor neuropathy 50 CaM kinase II 50 Post operatively 50 dominantly inherited 50 fever chills nausea 50 thiazide diuretic 50 chronic prostatitis 50 multivariate analyzes 50 untreated OSA 50 osteopathic manipulation 50 tryptase 50 prefrontal cortical 50 unstable angina pectoris 50 irritability headaches 50 gastro esophageal reflux 50 neuro degenerative disorders 50 musculo skeletal pain 50 EGFR inhibitors 50 breast carcinoma 50 apolipoprotein E4 50 pulmonary dysfunction 50 amyloid deposition 50 severe hepatic insufficiency 50 Stimulant drugs 50 silent ischemia 50 hormone therapy estrogen 50 malignant prostate 50 schizophreniform 50 valvular heart disease 50 genetic polymorphisms 50 dysrhythmias 50 obstetric complications 50 impaired hepatic 50 severely immunosuppressed 50 ALDH2 deficient 50 2 diabetes UKPDS 50 Comorbidities 50 primary Restless Legs 50 thromboxane A2 50 vermis 50 pituitary tumors 50 PTPN# 50 excitotoxic 50 heart palpitations dizziness 50 noncardiovascular mortality 50 autoimmune thyroid 50 NATRECOR ® 50 dizziness insomnia 50 Coronary artery calcification 50 inflammatory markers 50 benign ovarian 50 LDL cholesterol lowering 50 mutant huntingtin protein 50 unfavorable prognostic 50 synovial fibroblasts 50 multi factorial disease 50 nongenetic 50 steatohepatitis 50 T1DM 50 hypercoagulability 50 nongenetic factors 50 puerperal psychosis 50 Osteopenia 50 neuropsychological functioning 50 ORMDL3 50 calcified plaques 50 metabolically healthy 50 symptomatology 50 postoperative infections 50 bladder incontinence 50 leucopenia 50 pharmacologic interventions 50 parasympathetic tone 50 System IPSS 50 apoC III 50 congenital deficiency 50 thrombophilia 50 osteopenia osteoporosis 50 cardiometabolic risk 50 extrapulmonary 50 cortical atrophy 50 psychotherapeutic interventions 50 lacunar 50 rates Tangka 50 adjuvant therapies 50 hypertension dyslipidemia 50 circulating endothelial cells 50 hsCRP levels 50 Vaginal dryness